LARIMAR THERAPEUTICS, INC. Notes Payable, Noncurrent
LARIMAR THERAPEUTICS, INC. (LRMR) had Notes Payable, Noncurrent of $6.75 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermNotesPayable · last filed 2020-05-07
- 2020-03-31: Notes Payable, Noncurrent $6.75M.
- 2019-12-31: Notes Payable, Noncurrent $8.46M.
- 2019-09-30: Notes Payable, Noncurrent $10.17M.
- 2019-06-30: Notes Payable, Noncurrent $11.85M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2020-03-31 | $6.75M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $8.46M 10-Q · filed 2020-05-07 |
| 2019-09-30 | $10.17M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $11.85M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $13.53M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $15.19M 10-K · filed 2020-03-05 |
| 2018-09-30 | $16.84M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $18.50M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $20.16M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $20.00M 10-K · filed 2019-03-14 |
| 2016-09-30 | $1.20M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.97M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $2.72M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.45M 10-K · filed 2017-03-10 |
| 2015-09-30 | $4.16M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $4.85M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $5.52M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $6.18M 10-K · filed 2016-03-15 |
| 2014-09-30 | $6.82M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $7.45M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |